Simcere Pharmaceutical Group Ltd (2096.HK)
Company Info
Highlights
HK$21.98B
28.65
HK$5.08 - HK$9.19
HK$9.88
Share Price Chart
Loading data...
Compare to other instruments
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Performance
Performance Chart
Loading data...
Returns By Period
Simcere Pharmaceutical Group Ltd (2096.HK) returned 26.50% year-to-date (YTD) and 57.22% over the past 12 months.
2096.HK
26.50%
12.83%
31.75%
57.22%
N/A
N/A
^GSPC (Benchmark)
-3.77%
7.44%
-5.60%
8.37%
14.12%
10.46%
Monthly Returns
The table below presents the monthly returns of 2096.HK, with color gradation from worst to best to easily spot seasonal factors. Returns are adjusted for dividends.
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Total | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025 | -1.71% | 14.93% | -0.50% | 11.03% | 1.37% | 26.50% | |||||||
| 2024 | -22.74% | 7.12% | -4.67% | 1.69% | 8.52% | 0.76% | -6.28% | 10.06% | 15.74% | 2.63% | -0.28% | 0.29% | 7.48% |
| 2023 | -6.71% | -5.90% | -19.12% | 12.12% | -17.95% | 4.62% | -5.15% | -16.98% | 4.75% | 6.56% | 8.21% | -8.81% | -40.73% |
| 2022 | -14.68% | 23.21% | 11.96% | -20.04% | 10.76% | -6.50% | -3.49% | -5.30% | -13.36% | 28.05% | 17.43% | 13.48% | 31.67% |
| 2021 | -5.92% | -3.80% | 1.48% | -0.24% | 31.46% | 31.42% | -30.19% | -20.08% | -12.56% | 19.06% | 14.53% | -3.33% | 1.79% |
| 2020 | -2.73% | -23.69% | 9.82% | -18.49% |
Risk-Adjusted Performance
Risk-Adjusted Performance Rank
With an overall rank of 90, 2096.HK is among the top 10% of stocks on our website when it comes to balancing risk and reward. Below is a breakdown of how it compares using common performance measures.
Risk-Adjusted Performance Indicators
The charts below present risk-adjusted performance metrics for Simcere Pharmaceutical Group Ltd (2096.HK) and compare them to a chosen benchmark (^GSPC). These indicators evaluate an investment's returns against its associated risks.
Loading data...
Dividends
Dividend History
Simcere Pharmaceutical Group Ltd provided a 1.98% dividend yield over the last twelve months, with an annual payout of HK$0.18 per share.
| Period | TTM | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Dividend | HK$0.18 | HK$0.18 | HK$0.18 | HK$0.18 | HK$0.18 |
Dividend yield | 1.98% | 2.50% | 2.61% | 1.51% | 2.01% |
Monthly Dividends
The table displays the monthly dividend distributions for Simcere Pharmaceutical Group Ltd. The dividends shown in the table have been adjusted to account for any splits that may have occurred.
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Total | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025 | HK$0.00 | HK$0.00 | HK$0.00 | HK$0.00 | HK$0.00 | HK$0.00 | |||||||
| 2024 | HK$0.00 | HK$0.00 | HK$0.00 | HK$0.00 | HK$0.00 | HK$0.18 | HK$0.00 | HK$0.00 | HK$0.00 | HK$0.00 | HK$0.00 | HK$0.00 | HK$0.18 |
| 2023 | HK$0.00 | HK$0.00 | HK$0.00 | HK$0.00 | HK$0.00 | HK$0.18 | HK$0.00 | HK$0.00 | HK$0.00 | HK$0.00 | HK$0.00 | HK$0.00 | HK$0.18 |
| 2022 | HK$0.00 | HK$0.00 | HK$0.00 | HK$0.00 | HK$0.00 | HK$0.18 | HK$0.00 | HK$0.00 | HK$0.00 | HK$0.00 | HK$0.00 | HK$0.00 | HK$0.18 |
| 2021 | HK$0.18 | HK$0.00 | HK$0.00 | HK$0.00 | HK$0.00 | HK$0.00 | HK$0.00 | HK$0.18 |
Dividend Yield & Payout
Dividend Yield
Simcere Pharmaceutical Group Ltd has a dividend yield of 1.98%, which is quite average when compared to the overall market.
Payout Ratio
Simcere Pharmaceutical Group Ltd has a payout ratio of 56.39%, which is quite average when compared to the overall market. This suggests that Simcere Pharmaceutical Group Ltd strikes a balance between reinvesting profits for growth and paying dividends to shareholders.
Drawdowns
Drawdowns Chart
The Drawdowns chart displays portfolio losses from any high point along the way. Drawdowns are calculated considering price movements and all distributions paid, if any.
Loading data...
Worst Drawdowns
The table below displays the maximum drawdowns of the Simcere Pharmaceutical Group Ltd. A maximum drawdown is a measure of risk, indicating the largest reduction in portfolio value due to a series of losing trades.
The maximum drawdown for the Simcere Pharmaceutical Group Ltd was 62.49%, occurring on Feb 5, 2024. The portfolio has not yet recovered.
The current Simcere Pharmaceutical Group Ltd drawdown is 31.77%.
Depth | Start | To Bottom | Bottom | To Recover | End | Total |
|---|---|---|---|---|---|---|
| -62.49% | Jul 2, 2021 | 640 | Feb 5, 2024 | — | — | — |
| -33.13% | Oct 30, 2020 | 131 | May 11, 2021 | 19 | Jun 8, 2021 | 150 |
| -6.79% | Jun 16, 2021 | 1 | Jun 16, 2021 | 7 | Jun 25, 2021 | 8 |
| -1.34% | Jun 29, 2021 | 1 | Jun 29, 2021 | 1 | Jun 30, 2021 | 2 |
Volatility
Volatility Chart
The chart below shows the rolling one-month volatility.
Loading data...
Financials
Financial Performance
The chart below illustrates the trends in the financial health of Simcere Pharmaceutical Group Ltd over time, highlighting three key metrics: Total Revenue, Earnings Before Interest and Taxes (EBIT), and Net Income.
Valuation
The Valuation section provides an overview of how Simcere Pharmaceutical Group Ltd is priced in the market compared to other companies in the Drug Manufacturers - Specialty & Generic industry. It includes key financial ratios that help investors assess whether the stock is undervalued or overvalued.
PE Ratio
The chart displays the Price-to-Earnings (P/E) ratio for 2096.HK, comparing it with other companies in the Drug Manufacturers - Specialty & Generic industry. Currently, 2096.HK has a P/E ratio of 28.6. This P/E ratio is in line with the industry average, suggesting the stock may be fairly valued relative to its earnings.
PS Ratio
This chart shows the Price-to-Sales (P/S) ratio for 2096.HK relative to other companies in the Drug Manufacturers - Specialty & Generic industry. Currently, 2096.HK has a P/S ratio of 3.3. This P/S ratio falls within the average range for the industry, suggesting the stock is fairly valued based on its revenue.
PB Ratio
The chart illustrates the Price-to-Book (P/B) ratio for 2096.HK in comparison with other companies in the Drug Manufacturers - Specialty & Generic industry. Currently, 2096.HK has a P/B value of 2.8. This P/B ratio is in line with the industry average, suggesting the stock is valued fairly in relation to its book value.
Income Statement
| TTM | |
|---|---|
Revenue | — |
Total Revenue | — |
Cost Of Revenue | — |
Gross Profit | — |
Operating Expenses | — |
Selling, General & Admin Expenses | — |
R&D Expenses | — |
Depreciation And Amortization | — |
Total Operating Expenses | — |
Income | — |
Income Before Tax | — |
Operating Income | — |
EBITDA | — |
EBIT | — |
Earnings From Continuing Operations | — |
Net Income | — |
Income Tax Expense | — |
Other Non-Operating Income (Expenses) | — |
Extraordinary Items | — |
Discontinued Operations | — |
Effect Of Accounting Charges | — |
Non Recurring | — |
Minority Interest | — |
Other Items | — |
Interest Income | — |
Interest Expense | — |
Net Interest Income | — |